{"url_path":"/sec/olma/10-q/2026/item-2","section_key":"item-2","section_title":"Item 2 Unregistered Sales of Equity Securities and Use of Proceeds.","topic":"sec","document":{"doc_type":"10-Q","doc_date":"2026-05-12","source_url":"https://www.sec.gov/Archives/edgar/data/1750284/0001193125-26-218156-index.html","accession_number":"0001193125-26-218156","cik":"0001750284","ticker":"OLMA","issuer_name":"Olema Pharmaceuticals, Inc.","edgar_url":"https://www.sec.gov/Archives/edgar/data/1750284/0001193125-26-218156-index.html","primary_entity_key":"0001750284","primary_entity_name":"Olema Pharmaceuticals, Inc."},"word_count":62,"has_tables":true,"body_markdown":"# Item 2. Unregistered Sales of Equity Securities and Use of Proceeds.\n\nRecent Sales of Unregistered Securities\n\nThere were no sales of equity securities during the period covered by this report that were not registered under the Securities Act and were not previously reported in a Current Report on Form 8-K filed by the Company.\n\nRepurchase of Shares of Company Equity Securities\n\nNone."}